0.882

4.22% -0.0389

After Hours: .88 -0.002 -0.23%

Biodesix Inc (BDSX)

Overview News Price History Option Chain Financials Discussions Forecast

Biodesix Inc stock is traded at $0.882, with a volume of 241.86K. It is down -4.22% in the last 24 hours and down -17.57% over the past month. Biodesix Inc is a diagnostic solutions company with a focus in lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources, providing diagnostic testing services associated with blood-based lung and Coronavirus Disease 2019 (COVID-19) tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties as well as development and commercialization of companion diagnostics.

Previous Close:

$0.9209

Open:

$0.92

24h Volume:

241.86K

Relative Volume:

0.51

Market Cap:

$128.30M

Revenue:

$49.09M

Net Income/Loss:

$-52.15M

P/E Ratio:

-1.3569

EPS:

-0.65

Net Cash Flow:

$-45.93M

1W Performance:

-10.46%

1M Performance:

-17.57%

6M Performance:

-50.45%

1Y Performance:

-39.59%

1-Day Range:

$0.875

$0.9686

1-Week Range:

$0.875

$1.02

52-Week Range:

$0.8568

$2.04

Biodesix Inc Stock (BDSX) Company Profile

Name

Biodesix Inc

Sector

Healthcare (1169)

Industry

Diagnostics & Research (60)

Phone

303-417-0500

Address

919 WEST DILLON ROAD, LOUISVILLE

Employee

217

Twitter

Next Earnings Date

2024-11-27

Latest SEC Filings

BDSX's Discussions on Twitter

Compare BDSX with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
BDSX Biodesix Inc	0.882	128.30M	49.09M	-52.15M	-45.93M	-0.65
TMO Thermo Fisher Scientific Inc	532.55	203.70B	42.88B	6.34B	7.27B	16.53
DHR Danaher Corp	210.23	151.18B	23.88B	3.90B	5.30B	5.28
A Agilent Technologies Inc	135.37	38.62B	6.51B	1.29B	1.37B	4.42
IDXX Idexx Laboratories Inc	452.77	37.07B	3.90B	887.87M	808.08M	10.67
IQV Iqvia Holdings Inc	191.04	33.64B	15.41B	1.37B	2.11B	7.50

Biodesix Inc Stock (BDSX) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Sep-16-24	Initiated	Scotiabank	Sector Outperform
Jul-26-24	Initiated	Craig Hallum	Buy
May-13-24	Initiated	TD Cowen	Buy
May-03-24	Initiated	Lake Street	Buy
Nov-17-21	Downgrade	Morgan Stanley	Overweight → Equal-Weight
Nov-23-20	Initiated	BTIG Research	Buy
Nov-23-20	Initiated	Canaccord Genuity	Buy
Nov-23-20	Initiated	Morgan Stanley	Overweight
Nov-23-20	Initiated	William Blair	Outperform

View All

Biodesix Inc Stock (BDSX) Latest News

Feb 18, 2025

Biodesix, Inc. to Release Fourth Quarter and Full Year 2024 Financial Results on March 3, 2025 - Nasdaq

Feb 18, 2025

Biodesix to Report Fourth Quarter and Full Year 2024 Financial Results on March 3, 2025 - GlobeNewswire

Feb 18, 2025

Feb 17, 2025

Insider Selling: Biodesix, Inc. (NASDAQ:BDSX) CEO Sells 83,660 Shares of Stock - MarketBeat

Feb 17, 2025

Biodesix, Inc. (NASDAQ:BDSX) Insider Gary Anthony Pestano Sells 16,748 Shares - MarketBeat

Feb 17, 2025

Biodesix, Inc. (NASDAQ:BDSX) CFO Robin Harper Cowie Sells 24,664 Shares - MarketBeat

Feb 17, 2025

Feb 16, 2025

Stephens Inc. AR Makes New $303,000 Investment in Biodesix, Inc. (NASDAQ:BDSX) - Defense World

Feb 16, 2025

Feb 15, 2025

Biodesix chief accounting officer Chris Vazquez sells $3,354 in stock By Investing.com - Investing.com Australia

Feb 12, 2025

Biodesix CEO Scott Hutton sells shares worth $77,318 By Investing.com - Investing.com Australia

Feb 12, 2025

Biodesix chief commercial officer sells shares worth $16,198 By Investing.com - Investing.com Australia

Feb 12, 2025

Biodesix CFO sells $22,794 in stock By Investing.com - Investing.com Australia

Feb 12, 2025

BIODESIX Executives Sell Shares to Cover Taxes - TradingView

Feb 12, 2025

Feb 06, 2025